Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.

@article{Rao2006CombinationOP,
  title={Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.},
  author={Ravi D. Rao and Shernan Grace Holtan and James N. Ingle and Gary A. Croghan and Lisa A. Kottschade and Edward T. Creagan and Judith Salmon Kaur and Henry C. Pitot and Svetomir N. Markovic},
  journal={Cancer},
  year={2006},
  volume={106 2},
  pages={375-82}
}
BACKGROUND Patients with metastatic melanoma (MM) have very few therapy options. Based on reports of responses to paclitaxel and carboplatin (PC), 31 patients with MM were treated with PC. METHODS Data regarding patients treated with PC were abstracted from medical records. Clinical outcomes as determined by the treating oncologist were used for this analysis. Response determination was retrospectively confirmed using Response Evaluation Criteria in Solid Tumors (RECIST). RESULTS Thirty-one… CONTINUE READING
34 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Similar Papers

Loading similar papers…